The market was valued at approximately $160 million in 2013. The echocardiolab lab CVIS solution accounted for the majority of the market share in 2013 and is expected to undergo the largest growth, according to the news release.
The growth of the CVIS market is partly attributed to efforts to reduce mortality rates from cardiovascular diseases, efforts to streamline workflow across cardiovascular departments and the push to overcome “data silos,” according to the news release.
Prominent players in the CVIS market include McKesson Corp., Philips Healthcare, Siemens Healthcare, Agfa HealthCare and GE Healthcare.
More Articles on the Medical Device Market:
What the Increase in Device Recalls Means for Hospitals
Ophthalmology Device Market to Reach $9.5B by 2018
U.S. Vascular Access Device Market to Surpass $2B by 2022
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
